PHARMA 4.0

Sales & Marketing

With healthcare marketing becoming more digital than ever, artificial intelligence (AI) for marketers has ceased to be merely a buzzword.

Partner Content

Partner Content

Parallel Trade Conference

News

Roche remains confident in the prospects for its soon-to-be-filed oral BTK drug fenebrutinib for multiple sclerosis, despite safety concerns.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.